FDA Approves Groundbreaking Cell-Based Gene Therapies for Sickle Cell Disease
Stacy M. Brown NNPA Newswire Senior National Correspondent The U.S. Food and Drug Administration (FDA) has greenlit two revolutionary cell-based gene therapies, Casgevy and Lyfgenia, marking a significant leap forward in treating sickle cell disease […]
